About this trial

This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.

Eligibility criteria

Qualifiers

Age >= 18 years

Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer [BC], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ [LCIS], or prior chest wall radiation)

Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)

Able to read and understand English

Disqualifiers

Prisoners

Not able to speak and understand English

Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC

Trial design

Treatments tested in this trial

  • Follow-Up
  • Physical Examination
  • Questionnaire Administration

Treatment groups

960 Participants
are divided into 1 treatment group

Locations

1
Ohio State University Comprehensive Cancer Center43210, ColumbusOhio, United States

Sponsors and collaborators

Ohio State University Comprehensive Cancer Center

Lead sponsor